RAP media thread., page-2495

Hey all
Just thought id throw it out there, for anyone who's interested there is an upcoming Oz Biotech investment showcase on the 26th October 2021.
ResApp is presenting.

https://www.resapphealth.com.au/investor-relations/events-and-presentations/



My bet is they will release the COVID-19  preliminary results by then as it is expected they will be ready before this month is out, the Indian study would be completed for sure or by then, the US one I would continue to suspect a uptick in progress, with the recent enticement of the $30 gift card and free test on completion of the study.... until then I'm hoping that we will also see another sign- up of an additional partner before the Biotech conference to help this baby fly and create further interest at the conference...

I continue to suspect that this technology will have the power to identify symptomatic and asymptomatic COVID-19 respiratory cases with decent accuracy more so than the accuracy of the rapid antigen testing currently being used.  On that note - one of the most high-profile concerns surrounding rapid antigen testing is their accuracy. Accuracy levels tend to only test positive just before the onset of symptoms and for a week once symptoms have set in, so they are known to be more likely to return a false negative or false positive compared to a PCR test. The rapid antigen test around $12 to $20, however ResApp's screening tool could be more accurate, faster and cheaper!!!

If my thoughts are correct we will see the share price escalate rapidly from here IMO, my guess 5 bags warranted just on positive preliminary data.
LET'S DO THIS RESAPP!! GET THIS TO ALL ON AND BEHIND THE LINE ASAP!!

Cheers

Red bar